Extended Data Fig. 5: Parameters assessed using the EORTC QLQ-C30 questionnaire to evaluate the quality of life in patients with leptomeningeal disease from any solid tumor.
The questionnaires were carried out during the treatment period in cycles 1, 3, 5 and 8, and end of treatment. N represents the number of patients assessed in each cycle.
